DTASelect v2.0.39
/home/mauraisa/sequest_data/Thompson_lab_samples/Ari/pad_auto/ms2/20190912_Thompson_PAD2_trypsin_t1
/home/mauraisa/dbase/Human_uniprot-reviewed_Weerapana_Lab_10202017_rev.fasta
SEQUEST 3.0 in SQT format.
 --trypstat -m 0
true	Use criteria
0.0	Minimum peptide probability
0.05	Peptide global false discovery rate
0.0	Minimum protein probability
1.0	Protein false discovery rate
1	Minimum charge state
16	Maximum charge state
0.0	Minimum ion proportion
1000	Maximum Sp rank
-1.0	Minimum Sp score
Require	Modified peptide inclusion
Any	Tryptic status requirement
false	Multiple, ambiguous IDs allowed
Ignore	Peptide validation handling
XCorr	Purge duplicate peptides by protein
false	Include only loci with unique peptide
true	Remove subset proteins
Ignore	Locus validation handling
0	Minimum modified peptides per locus
2	Minimum peptides per locus

Locus	Sequence Count	Spectrum Count	Sequence Coverage	Length	MolWt	pI	Validation Status	Descriptive Name
Unique	FileName	XCorr	DeltCN	Conf%	M+H+	CalcM+H+	TotalIntensity	SpR	ZScore	IonProportion	Redundancy	Sequence
sp|Q9Y2J8|PADI2_HUMAN	46	119	52.3%	665	75564	5.6	U	Protein-arginine deiminase type-2 OS=Homo sapiens GN=PADI2 PE=1 SV=2 
*	20190912_Thompson_PAD2_trypsin_t1_01.10317.10317.2	2.5311	0.1522	98.8	2579.222	2578.2173	4455.3	1	4.077	43.2	1	K.HSEHVWVEVVR*DGEAEEVATNGK.Q
*	20190912_Thompson_PAD2_trypsin_t1_01.12088.12088.3	5.4637	0.4308	95.5	2578.2148	2578.2173	6357.9	1	7.975	30.7	19	K.HSEHVWVEVVR*DGEAEEVATNGK.Q
*	20190912_Thompson_PAD2_trypsin_t1_01.10331.10331.4	4.9582	0.3747	98.1	2578.2175	2578.2173	10301.2	1	6.15	25.8	44	K.HSEHVWVEVVR*DGEAEEVATNGK.Q
*	20190912_Thompson_PAD2_trypsin_t1_01.10589.10589.5	4.4506	0.2618	99.3	2578.235	2578.2173	9129.3	2	5.18	22.2	3	K.HSEHVWVEVVR*DGEAEEVATNGK.Q
*	20190912_Thompson_PAD2_trypsin_t1_01.09894.09894.5	4.6436	0.3512	98.6	2862.3743	2862.377	8873.5	1	7.048	25.0	1	K.HSEHVWVEVVRDGEAEEVATNGKQR*.W
*	20190912_Thompson_PAD2_trypsin_t1_01.09881.09881.4	3.4251	0.3376	98.9	2863.3762	2863.361	5085.8	1	5.156	29.2	1	K.HSEHVWVEVVR*DGEAEEVATNGKQR*.W
*	20190912_Thompson_PAD2_trypsin_t1_01.13879.13879.2	2.4279	0.2719	100.0	1458.8042	1458.8069	7325.8	1	4.526	59.1	1	K.QR*WLLSPSTTLR.V
*	20190912_Thompson_PAD2_trypsin_t1_01.13916.13916.3	2.7545	0.2589	99.4	1458.806	1458.8069	7215.0	6	4.635	45.5	1	K.QR*WLLSPSTTLR.V
*	20190912_Thompson_PAD2_trypsin_t1_01.17091.17091.3	3.9323	0.278	99.2	2882.4155	2882.4207	9575.6	3	5.419	26.0	1	K.QR*WLLSPSTTLR*VTMSQASTEASSDK.V
*	20190912_Thompson_PAD2_trypsin_t1_01.15121.15121.3	3.1955	0.2143	99.5	2597.279	2597.2769	6181.0	1	4.375	27.2	1	R.WLLSPSTTLR*VTMSQASTEASSDK.V
*	20190912_Thompson_PAD2_trypsin_t1_01.14480.14480.3	2.334	0.3643	100.0	2412.1956	2411.1975	4493.0	34	6.791	15.9	1	W.LLSPSTTLR*VTMSQASTEASSDK.V
*	20190912_Thompson_PAD2_trypsin_t1_01.24109.24109.4	3.967	0.2513	99.4	4371.1587	4370.1455	6863.6	6	4.425	14.5	2	K.VTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADR*DGVVEK.N
*	20190912_Thompson_PAD2_trypsin_t1_01.15482.15482.3	3.9414	0.23	99.4	2359.1545	2359.1504	8768.4	2	4.898	35.0	1	K.KASWTWGPEGQGAILLVNCDR*.E
*	20190912_Thompson_PAD2_trypsin_t1_01.17678.17678.3	5.514	0.399	97.2	3210.603	3210.6045	6629.3	1	6.987	28.7	2	K.KASWTWGPEGQGAILLVNCDR*ETPWLPK.E
*	20190912_Thompson_PAD2_trypsin_t1_01.17743.17743.4	3.3902	0.2418	99.4	3210.5984	3210.6045	7245.6	9	4.545	21.0	1	K.KASWTWGPEGQGAILLVNCDR*ETPWLPK.E
*	20190912_Thompson_PAD2_trypsin_t1_01.15412.15412.4	3.0252	0.1649	98.4	4142.958	4142.97	7699.0	192	4.517	17.2	1	K.KASWTWGPEGQGAILLVNCDRETPWLPKEDCR*DEK.V
*	20190912_Thompson_PAD2_trypsin_t1_01.16350.16350.4	4.8993	0.1372	99.1	4143.951	4143.9546	13012.0	2	3.721	15.7	1	K.KASWTWGPEGQGAILLVNCDR*ETPWLPKEDCR*DEK.V
*	20190912_Thompson_PAD2_trypsin_t1_01.16851.16851.3	4.6128	0.3174	98.8	2231.0588	2231.0554	7740.9	1	6.272	35.5	1	K.ASWTWGPEGQGAILLVNCDR*.E
*	20190912_Thompson_PAD2_trypsin_t1_01.09006.09006.3	2.6315	0.0871	95.1	1803.8196	1803.8223	7461.7	9	3.515	32.7	1	R.ETPWLPKEDCR*DEK.V
*	20190912_Thompson_PAD2_trypsin_t1_01.12739.12739.4	4.0654	0.2943	99.1	2889.342	2889.3433	8760.2	1	5.881	28.0	1	K.EDCR*DEKVYSKEDLKDMSQMILR.T
*	20190912_Thompson_PAD2_trypsin_t1_01.13010.13010.3	3.2911	0.1578	98.8	2186.1196	2186.12	8658.6	166	4.467	29.4	1	K.VYSKEDLKDMSQMILR*TK.G
*	20190912_Thompson_PAD2_trypsin_t1_01.13745.13745.3	2.6217	0.1765	99.1	1708.8586	1708.8613	9933.9	180	3.906	34.6	1	K.EDLKDMSQMILR*TK.G
*	20190912_Thompson_PAD2_trypsin_t1_01.11750.11750.2	1.9176	0.1073	96.5	1223.6119	1223.6128	5594.9	43	3.657	66.7	1	K.DMSQMILR*TK.G
*	20190912_Thompson_PAD2_trypsin_t1_01.21044.21044.5	3.9953	0.364	98.5	4296.1504	4296.133	5893.3	4	6.088	15.9	1	R.TKGPDR*LPAGYEIVLYISMSDSDKVGVFYVENPFFGQR.Y
*	20190912_Thompson_PAD2_trypsin_t1_01.11128.11128.4	4.0266	0.0817	96.8	2175.031	2174.0122	7569.9	123	4.041	25.0	1	K.TNCELKVCFQYLNR*GDR.W
*	20190912_Thompson_PAD2_trypsin_t1_01.10749.10749.2	2.129	0.1144	96.8	1100.5156	1100.5199	4032.0	28	3.192	57.1	1	K.VCFQYLNR*.G
*	20190912_Thompson_PAD2_trypsin_t1_01.10630.10630.2	2.7026	0.1144	97.8	1428.6688	1428.6694	8339.4	13	4.618	60.0	1	K.VCFQYLNR*GDR.W
*	20190912_Thompson_PAD2_trypsin_t1_01.17950.17950.4	4.3081	0.3038	99.0	3384.6094	3384.611	9686.1	1	6.077	26.3	1	K.VCFQYLNRGDR*WIQDEIEFGYIEAPHK.G
*	20190912_Thompson_PAD2_trypsin_t1_01.19114.19114.4	2.731	0.2666	99.4	3385.5947	3385.5952	9641.7	50	4.391	22.4	1	K.VCFQYLNR*GDR*WIQDEIEFGYIEAPHK.G
*	20190912_Thompson_PAD2_trypsin_t1_01.17725.17725.5	4.6806	0.0908	97.1	4454.2056	4452.1875	7799.9	1	4.86	17.7	1	K.VCFQYLNR*GDRWIQDEIEFGYIEAPHKGFPVVLDSPR.D
*	20190912_Thompson_PAD2_trypsin_t1_01.17726.17726.6	3.2048	0.2616	99.4	4452.2	4452.1875	9803.9	324	4.6	17.2	1	K.VCFQYLNR*GDRWIQDEIEFGYIEAPHKGFPVVLDSPR.D
*	20190912_Thompson_PAD2_trypsin_t1_01.16992.16992.3	4.4053	0.3187	100.0	2979.4243	2979.4277	9567.4	1	6.03	34.8	1	F.QYLNR*GDR*WIQDEIEFGYIEAPHK.G
*	20190912_Thompson_PAD2_trypsin_t1_01.16186.16186.5	5.2548	0.425	96.2	3372.6875	3371.67	10065.8	3	5.839	25.0	1	R.GDRWIQDEIEFGYIEAPHKGFPVVLDSPR*.D
*	20190912_Thompson_PAD2_trypsin_t1_01.14418.14418.3	4.2497	0.3459	98.6	2201.1592	2201.1606	9934.4	2	6.34	34.2	1	K.GFPVVLDSPR*DGNLKDFPVK.E
*	20190912_Thompson_PAD2_trypsin_t1_01.18614.18614.3	2.9843	0.1522	98.4	2510.341	2510.344	10878.5	1	3.484	30.7	2	K.TYPLGR*ILIGSSFPLSGGR*R*MTK.V
*	20190912_Thompson_PAD2_trypsin_t1_01.13495.13495.2	2.3817	0.2963	100.0	1460.8208	1460.8225	5899.1	2	5.123	46.2	2	R.ILIGSSFPLSGGR*R.M
*	20190912_Thompson_PAD2_trypsin_t1_01.13497.13497.3	1.753	0.1309	96.0	1460.8182	1460.8225	5739.2	10	3.693	32.7	1	R.ILIGSSFPLSGGR*R.M
*	20190912_Thompson_PAD2_trypsin_t1_01.14450.14450.2	4.8449	0.2111	100.0	1954.0063	1953.9922	7757.7	1	4.55	66.7	3	K.ILSNESLVQENLYFQR*.C
*	20190912_Thompson_PAD2_trypsin_t1_01.19232.19232.3	3.4743	0.266	99.3	2651.2383	2651.242	7066.8	2	5.066	29.8	1	K.MDEDHR*AR*AFFPNMVNMIVLDK.D
*	20190912_Thompson_PAD2_trypsin_t1_01.19881.19881.4	5.2951	0.2395	99.3	4362.115	4361.094	7039.8	1	5.423	21.8	1	R.AFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVR*.G
*	20190912_Thompson_PAD2_trypsin_t1_01.19029.19029.5	5.0054	0.3535	98.4	4361.074	4361.094	8432.3	2	5.922	18.8	2	R.AFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVR*.G
*	20190912_Thompson_PAD2_trypsin_t1_01.14870.14870.5	3.7928	0.3089	100.0	3441.6848	3440.6726	8047.1	106	5.075	21.0	1	N.MIVLDKDLGIPKPFGPQVEEECCLEMHVR*.G
*	20190912_Thompson_PAD2_trypsin_t1_01.13860.13860.4	4.9393	0.4006	97.3	2743.2944	2741.2737	7127.4	1	6.665	28.8	3	K.DLGIPKPFGPQVEEECCLEMHVR*.G
*	20190912_Thompson_PAD2_trypsin_t1_01.21812.21812.5	4.7914	0.3056	100.0	3705.8276	3704.8093	8667.7	8	5.509	18.5	1	G.LLEPLGLECTFIDDISAYHKFLGEVHCGTNVR*.R
*	20190912_Thompson_PAD2_trypsin_t1_01.07249.07249.2	1.4927	0.2027	98.2	1545.7561	1545.7596	5386.7	18	4.068	33.3	1	K.FLGEVHCGTNVR*R.K
*	20190912_Thompson_PAD2_trypsin_t1_01.07279.07279.3	2.545	0.2266	99.5	1545.7585	1545.7596	7649.0	8	4.731	37.5	2	K.FLGEVHCGTNVR*R.K
sp|Q9ULC6|PADI1_HUMAN	6	8	13.0%	663	74666	6.5	U	Protein-arginine deiminase type-1 OS=Homo sapiens GN=PADI1 PE=1 SV=2 
*	20190912_Thompson_PAD2_trypsin_t1_01.13713.13713.2	2.6154	0.4797	100.0	1889.9268	1888.9227	5071.9	1	6.845	37.5	3	R.VSGSSGVEVFMVYNR*TR.V
*	20190912_Thompson_PAD2_trypsin_t1_01.14047.14047.3	3.0574	0.2823	99.3	2118.0715	2117.07	7657.8	21	4.955	36.1	1	R.VSGSSGVEVFMVYNR*TR*VK.E
*	20190912_Thompson_PAD2_trypsin_t1_01.15521.15521.3	2.3667	0.2642	99.5	2120.0254	2120.0334	5733.4	13	4.661	23.7	1	K.AR*WPLDTDADMVVSVGTASK.E
*	20190912_Thompson_PAD2_trypsin_t1_01.15904.15904.3	2.0972	0.1184	95.7	2398.1885	2392.1873	6511.1	189	3.413	23.7	1	K.KTWR*WGPEGYGAILLVNCDR.D
	20190912_Thompson_PAD2_trypsin_t1_01.17348.17348.2	1.8097	0.3192	100.0	1394.6926	1394.7432	2851.1	12	5.077	36.4	1	K.R*ILGPDFGYVTR.E
*	20190912_Thompson_PAD2_trypsin_t1_01.13047.13047.3	2.8429	0.3583	98.8	1658.9265	1658.927	5099.2	1	6.11	41.1	1	K.YLGIPKPYGPIINGR*.C
Reverse_sp|Q15695|U2AFL_HUMAN	2	2	6.1%	479	57643	9.4	U	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1 OS=Homo sapiens GN=ZRSR1 PE=2 SV=2 
*	20190912_Thompson_PAD2_trypsin_t1_01.09531.09531.3	1.835	0.1024	95.1	1587.779	1585.7834	3866.7	101	3.03	33.3	1	R.KYTHDPSPNR*R*GR.Q
	20190912_Thompson_PAD2_trypsin_t1_01.13698.13698.3	2.0746	0.1339	96.2	2077.0586	2071.9482	5255.9	2	3.178	30.0	1	R.TVPCFECQLQRGAYWR*.G
	Proteins	Peptide IDs	Spectra
Unfiltered	15445	23307	35545
Filtered	3	54	129
Forward matches	2	52	127
Decoy matches	1	2	2
Forward FP rate	50.0	3.85	1.57

Classification	Nonredundant Proteins	Redundant Proteins
Unclassified	0	0
